The UVA Manning Institute of Biotechnology will bring together top researchers whose work spans the full spectrum of Alzheimer’s disease, from understanding its earliest mechanisms to identifying new treatment targets. By uniting researchers and resources under one roof, the Manning Institute will accelerate the path from discovery to clinical trials — a capability that few academic centers in the world will be able to match.
In this new video, School of Medicine researchers discuss what the Manning Institute will make possible in the quest to find cures and treatments for Alzheimer’s and other neurodegenerative diseases. Featured researchers include:
John Lukens, PhD, professor of neuroscience and inaugural director of the Manning Institute’s Harrison Family Translational Research Center in Alzheimer’s and Neurodegenerative Diseases
Xuemei Huang, MD, PhD, professor and chair of the Department of Neurology
Jaideep Kapur, PhD, professor in the Department of Neurology, Division of Epilepsy, and director of UVA Brain Institute
Lori L. McMahon, PhD, professor in the Department of Neuroscience and vice president for research at the University of Virginia
Harald Sontheimer, PhD, professor and chair of the Department of Neuroscience